AVITA Medical, Inc. (RCEL)

AVITA Medical Income Statement

Financials in millions AUD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	51.57	37.64	34.62	18.19	11.4
Revenue Growth (YoY)	37.03%	8.73%	90.31%	59.62%	31.54%
Cost of Revenue	7.78	6.04	6.1	2.97	1.27
Gross Profit	43.79	31.6	28.51	15.22	10.12
Selling, General & Admin	65.63	45.24	37.96	48.73	27.65
Research & Development	20.82	13.86	15.67	9.16	8
Operating Expenses	86.45	59.1	53.63	57.9	35.65
Operating Income	-42.66	-27.51	-25.12	-42.68	-25.53
Interest Expense / Income	1.14	0.02	0.03	0.03	0.03
Other Expense / Income	-8.48	-0.89	-0.05	-0.69	-0.33
Pretax Income	-35.32	-26.63	-25.1	-42.03	-25.22
Income Tax	0.07	0.04	0.04	0	-0.12
Net Income	-35.38	-26.67	-25.14	-42.03	-25.1
Shares Outstanding (Basic)	25	25	25	20	16
Shares Outstanding (Diluted)	25	25	25	20	16
Shares Change	1.32%	0.30%	22.84%	26.31%	72.24%
EPS (Basic)	-1.40	-1.07	-1.01	-2.07	-1.56
EPS (Diluted)	-1.40	-1.07	-1.01	-2.07	-1.56
Free Cash Flow	-39.39	-19.54	-5.57	-23.34	-20.27
Free Cash Flow Per Share	-1.55	-0.78	-0.22	-1.15	-1.26
Gross Margin	84.91%	83.95%	82.37%	83.65%	88.85%
Operating Margin	-82.71%	-73.08%	-72.56%	-234.64%	-224.03%
Profit Margin	-68.61%	-70.85%	-72.63%	-231.07%	-220.29%
Free Cash Flow Margin	-76.38%	-51.92%	-16.08%	-128.30%	-177.89%
EBITDA	-32.79	-25.35	-24.41	-41.03	-24.93
EBITDA Margin	-63.59%	-67.36%	-70.53%	-225.55%	-218.75%
Depreciation & Amortization	1.38	1.26	0.66	0.97	0.27
EBIT	-34.17	-26.61	-25.07	-41.99	-25.2
EBIT Margin	-66.26%	-70.71%	-72.43%	-230.87%	-221.11%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).